ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)
May 26, 2021Sinovant Sciences today announced positive topline results from Sinovant's Phase 3 bridging study of lefamulin in Chinese adults with community acquired bacterial pneumonia (CABP). -
Roivant and Sinovant launch biopharma firm Cytovant Sciences
April 09, 2019Roivant and Sinovant launch biopharma firm Cytovant Sciences -
Angion Biomedica, Sinovant Sciences collaborate to develop BB3
November 19, 2018Angion is currently developing BB3 in a Phase 3 trial for the treatment of delayed graft function (DGF) following kidney transplantation and in a Phase 2 trial for the treatment of acute kidney injury (AKI) following open-heart surgery requiring cardiopul
Pharma Sources Insight January 2025
